In this paper, we describe a protocol for generating CD133-specific CAR-T cells secreting PD-1 blocking single-chain variable fragment (scFv) targeting HCC cells using an SB-based nonviral genetic modification system involving MC transposon donor vectors to simplify the current CAR-T cell production protocol. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.